| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 16.88B | 15.57B | 15.14B | 19.83B | 13.75B | 4.35B |
| Gross Profit | 3.92B | 4.27B | 5.20B | 8.97B | 5.21B | -252.00M |
| EBITDA | 7.76B | 7.43B | 7.57B | 10.38B | 5.42B | -1.36B |
| Net Income | 2.72B | 2.89B | 3.75B | 6.01B | 2.78B | -2.68B |
Balance Sheet | ||||||
| Total Assets | 31.22B | 30.49B | 24.49B | 23.72B | 21.02B | 9.91B |
| Cash, Cash Equivalents and Short-Term Investments | 1.28B | 846.00M | 875.00M | 1.45B | 2.10B | 2.05B |
| Total Debt | 8.55B | 9.20B | 6.45B | 6.70B | 6.73B | 4.54B |
| Total Liabilities | 15.87B | 15.79B | 12.27B | 12.43B | 11.63B | 6.89B |
| Stockholders Equity | 15.35B | 14.50B | 12.06B | 11.17B | 9.26B | 2.88B |
Cash Flow | ||||||
| Free Cash Flow | 3.03B | -853.00M | 2.60B | 3.40B | 2.89B | 193.00M |
| Operating Cash Flow | 6.84B | 6.60B | 6.54B | 8.53B | 4.90B | 1.35B |
| Investing Cash Flow | -3.47B | -7.33B | -3.94B | -5.12B | -1.57B | -646.00M |
| Financing Cash Flow | -2.77B | 706.00M | -3.18B | -4.21B | -3.29B | -306.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | $45.59B | 11.06 | 10.92% | 2.70% | 60.29% | -17.62% | |
79 Outperform | $24.75B | 9.28 | 18.35% | 2.64% | 11.14% | -21.32% | |
78 Outperform | $123.41B | 14.13 | 15.37% | 3.43% | 8.41% | -16.12% | |
76 Outperform | $33.96B | 18.56 | 8.19% | 1.17% | 64.84% | 219.47% | |
73 Outperform | $20.95B | 12.70 | 11.86% | 3.39% | 26.13% | 31.42% | |
66 Neutral | $43.89B | 32.42 | 5.82% | 2.39% | -2.48% | -65.26% | |
65 Neutral | $15.17B | 7.61 | 4.09% | 5.20% | 3.87% | -62.32% |